See the DrugPatentWatch profile for cosentyx

Based on the provided sources, there is no specific information about the risks of live vaccines post Cosentyx (secukinumab) treatment. However, I can provide some general context about Cosentyx and live vaccines.

Cosentyx is a prescription medicine used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It belongs to a class of drugs called biologics, which are medications made from living organisms or their components [1].

Regarding live vaccines and biologics like Cosentyx, there is a general understanding that biologics may affect the immune system's response to vaccines [2]. Live vaccines contain weakened forms of the viruses or bacteria they protect against [3]. Since biologics like Cosentyx can influence the immune system, live vaccines may not produce an adequate immune response, or there could be an increased risk of adverse effects [2].

However, the specific risks of live vaccines post Cosentyx treatment are not addressed in the provided sources. It is essential to consult a healthcare professional for personalized advice on this matter.

Sources:

[1] DrugPatentWatch. (n.d.). COSENTYX. Retrieved from <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>

[2] COVID-19 (Coronavirus) and COSENTYX. (n.d.). Retrieved from <https://www.cosentyx.com/all/covid19>

[3] Gershon, A. A. (2021). Live Viral Vaccines. In StatPearls. StatPearls Publishing. <https://www.ncbi.nlm.nih.gov/books/NBK534825/>